Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: J Gastrointest Surg. 2019 Feb 26;23(12):2362–2371. doi: 10.1007/s11605-019-04165-5

Table 3.

Postoperative factors based on timing of RIOT readiness*

Factor Total Early RIOT Delayed RIOT P value

 No. of patients 114 82 32
 Time to postoperative visit (days) 10 (9, 13) 10 (9, 12) 13 (10, 17) 0.009
 Wound status <0.001
 Dry 102 (89) 79 (96) 23 (72)
 Drainage 10 (9) 2 (2) 8 (25)
 Infected 2 (2) 1 (1) 1 (3)
 Use of opioids 35 (32) 22 (28) 13 (42) 0.174
 Hemoglobin (gm/dL) 11.5 (10.4, 12.8) 12.0 (11.0, 12.9) 10.7 (9.7, 12.6) 0.004
 White blood cell count (K/uL) 7.3 (5.7, 9.1) 7.4 (5.9, 8.8) 7.2 (5.3, 10.6) 0.798
 Neutrophil/Lymphocyte ratio 3.4 (2.6, 5.2) 3.3 (2.4, 4.7) 3.8 (3.0, 6.6) 0.034
 Platelet count (K/ul) 267 (224, 361) 267 (228, 369) 273 (201, 357) 0.711
 Albumin (gm/dL) 3.9 (3.7, 4.2) 4 (3.8, 4.4) 3.7 (3.3, 3.8) <0.001
 ECOG performance status <0.001
 0 3 (3) 2 (2) 1 (3)
 1 36 (32) 34 (41) 2 (6)
 2 62 (54) 43 (52) 19 (59)
 3 13 (11) 3 (4) 10 (31)
 Adjuvant chemotherapy recommended 63 (55) 45 (57) 18 (56) 1.000
*

Values are reported as number (percentage) or median (interquartile range [IQR])

RIOT, return to intended oncologic therapy; ECOG, Eastern Cooperative Oncology Group